About Prolacta Bioscience
Prolacta Bioscience is a company based in Los Angeles (United States) founded in 1999. Prolacta Bioscience has raised $98.72 million across 10 funding rounds from investors including PROOF, Aisling Capital and Health Evolution Partners. Prolacta Bioscience operates in a competitive market with competitors including Beingmate Baby Child Food, BoobyBiome, Lowenzahn Organics, Wellements and Pharmacia Laboratorij, among others.
- Headquarter Los Angeles, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$98.72 M (USD)
in 10 rounds
-
Latest Funding Round
$9 M (USD), Series E
May 14, 2018
-
Investors
PROOF
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Prolacta Bioscience
Unlock access to complete
Funding Insights of Prolacta Bioscience
Prolacta Bioscience has successfully raised a total of $98.72M across 10 strategic funding rounds. The most recent funding activity was a Series E round of $9 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Prolacta Bioscience
Prolacta Bioscience has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include PROOF, Aisling Capital and Health Evolution Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage technology companies are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
PE firm investing in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Prolacta Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prolacta Bioscience
Investment portfolio details for Prolacta Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prolacta Bioscience
Detailed financials for Prolacta Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prolacta Bioscience Comparisons
Peer comparison for Prolacta Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prolacta Bioscience
Prolacta Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beingmate Baby Child Food, BoobyBiome, Lowenzahn Organics, Wellements and Pharmacia Laboratorij, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of nutrition products for babies and children
|
|
| Locked | Locked | Locked |
Developer of probiotic supplement for babies
|
|
| Locked | Locked | Locked |
Food supplements for babies' growth and development are provided.
|
|
| Locked | Locked | Locked |
Organic baby wellness products and supplements are manufactured for infants.
|
|
| Locked | Locked | Locked |
Provides comprehensive baby formula products for infants and toddlers.
|
Detailed competitors of Prolacta Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prolacta Bioscience
Complete news archive for Prolacta Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prolacta Bioscience
Prolacta Bioscience was founded in 1999 and raised its 1st funding round 5 years after it was founded.
Prolacta Bioscience is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Prolacta Bioscience is a funded company, having raised a total of $98.72M across 10 funding rounds to date.
Founded in 1999 and based in Los Angeles, United States, Prolacta Bioscience operates in the biotechnology sector focused on neonatal nutrition. Standardized formulations derived from donated human breast milk are produced for premature infants in neonatal intensive care units. Surplus milk is sourced through affiliate milk banks. Key products include Prolact, Premielact Prolact HM, Prolact CR, and Prolact RTF, with clinical studies indicating improved health outcomes.
Prolacta Bioscience's top competitors include Beingmate Baby Child Food, BoobyBiome and Lowenzahn Organics.
Prolacta Bioscience has 13 investors. Key investors include PROOF, Aisling Capital, Health Evolution Partners, EW Healthcare Partners, and Alta Partners.